Blocked CDC COVID-19 Vaccine Study Published in JAMA Network Open Amid Scientific Integrity Dispute
A major controversy over scientific integrity and political interference in federal public health research has culminated in the publication of a previously blocked COVID-19 vaccine study in JAMA Network Open. This development comes amidst ongoing tension between the Department of Health and Human Services (HHS), led by Secretary Robert F. Kennedy, Jr., and federal scientists over the publication of vaccine-effectiveness data.
The JAMA Network Open Publication
The study, which evaluated the real-world effectiveness of updated COVID-19 vaccines, was originally prepared by researchers at the Centers for Disease Control and Prevention (CDC) for publication in the agency's highly regarded Morbidity and Mortality Weekly Report (MMWR). However, the manuscript was blocked from publication by HHS leadership, sparking a scientific integrity dispute and accusations of political interference in federal public health research.
Following the internal block, the researchers submitted the study to JAMA Network Open, a peer-reviewed medical journal, where it was successfully published. The study's findings demonstrated that updated COVID-19 vaccines provided substantial protection, reducing the risk of emergency department (ED) visits and hospitalizations among healthy adults by approximately half during the preceding winter season.
Ongoing Clashes Over Vaccine-Effectiveness Data
The blocking of the MMWR manuscript highlights a broader, ongoing clash over vaccine policy and scientific communication under HHS Secretary Robert F. Kennedy, Jr. In September 2025, an HHS vaccine advisory panel scrapped the federal government's broad recommendation for seasonal COVID-19 immunizations—a policy change that has since been temporarily blocked by a federal court.
HHS spokesperson Andrew Nixon defended the department's decision to reject the MMWR manuscript, citing concerns about the study's scientific rigor:
"The manuscript was not accepted for publication [due to concerns about the] methodological approach estimating vaccine effectiveness."
Despite these administrative objections, the successful peer-reviewed publication of the data in JAMA Network Open has reinforced concerns among public health advocates and federal scientists regarding the politicization of official agency channels like the MMWR, which physicians and state health departments rely on for objective, real-time clinical guidance.